Hybrid Nanofibers for Multimodal Accelerated Wound Healing.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 41601439.
- Also identified by DOI 10.1002/adhm.202504029 and PMC identifier 13088746.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Wound healing is a complex physiological process that demands multifunctional therapeutic approaches to ensure effective recovery. This study presents a straightforward approach using blend electrospinning to produce multimodal hybrid nanomaterials that accelerate the wound healing process. Poly(L-lactide-co-ε-caprolactone) (PLCL), cellulose acetate (CA), and polyethylene oxide (PEO) were utilized as biodegradable, compatible, and compliant polymers for generating nanofibers. Hybrid nanofibers functionalized with dexamethasone, ascorbic acid, and hyperbranched polymers introduce anti-inflammatory, regenerative, and antimicrobial properties. Pristine nanofibers with diameters of 0.818 ± 0.028 and 0.845 ± 0.039 µm were generated, while drug-loaded fibers with average diameters of 1.075 ± 0.055 and 1.235 ± 0.075 µm were obtained. The fibers demonstrated a porosity ranging from 72 % to 86 %. Further, attenuated total reflectance Fourier transform infrared spectroscopy (ATR-FTIR), thermogravimetric analysis (TGA), and contact angle, as well as zeta potential measurements, highlight the physicochemical properties of the fibers. In vivo studies of the nanofibers demonstrated that by day 11, there was a significant acceleration in wound healing. A remarkable acceleration was observed in cell proliferation, granulation, and remodeling phases. The findings emphasize the potential of multimodal hybrid nanofibers as advanced wound dressings and the importance of integrative strategies in wound care.
Medical subject headings
- Nanofibers
- Wound Healing